Tambi et al., J. Heterocyclic Chem., vol. 20 (1983) pp. 803-805. |
Nodiff et al., J. Heterocyclic Chem. vol. 5 (1968) pp. 165-177. |
C.A., 77p, 152198Y, 1972. |
Collier, Can. J. Med. Sci., 31, 195-201 (1953). |
Collier et al., Can. J. Biochem., 43, 105-110 (1965). |
Collier et al., Can. J. Biochem. & Phys., 33 773-779 (1955). |
Collier et al., Can. J. Res., 20B, 284-290 (1942). |
Wightman et al., Biochem J., 197, 523-526 (1981). |
Singh et al., Asian Medical J., 19, 60-66 (1976). |
Fishman et al., J. Pharm. Exp. Ther., 150, 122-128 (1965). |
Bailey et al., Ann. Rpts. Med. Chem., 17, 203-217 (1982). |
Bailey et al., Ann. Rpts. Med. Chem. 16, 213-227 (1981). |
Baumann et al., Prostaglandins 20, 627-639 (1980). |
Sandler, Chap. 16, "Inhibitors of Aarchidonic Acid Metabolism" from Enzyme Inhibitors as Drugs, Univ. Park Press, Baltimore, pp. 249-262. |
Mitchell, Drug Met. Rev. 13, 319-343 (1982). |
Ellison et al., Am. J. Vet. Res. No. 7, 519-522 (1957). |
Rigas et al., Prostaglandins Med., 183-193 (1981). |
Perel et al., Neurotoxicology, Raven Press, New York (1977) pp. 9-13. |
Halpern, Arch. Int'l Pharm. Ther., 74, 314-333 (1947). |
Bhargava et al., Gazz. Chem. Ital., 109, 201-203 (1979). |
Garry et al., Biochem. Pharm., 21, 2801-2804 (1972). |
Mitchell et al., Drug. Metab. Disp., 7, 399-403 (1979). |
Akera et al., Biochem. Pharm., 27, 995-998 (1978). |
Creese et al., Eur. J. Pharm., 47, 291-296 (1978). |
Schenker et al., Progress in Drug Res., 5, E. Tucker, ed. Birkhauser Verlag, Basel, Switzerland (1963) pp. 269-627. |